**Abstract**

KYN pathway (KP) is activated by pro-inflammatory cytokines and can produce pro-oxidative metabolites in the brain of depressed patients. Antidepressant treatment reverses oxidative stress in animal models, we can hypothesize that

In an animal model of \"chronic stress induced depression\" in mice, we previously showed that TRP/ KYN pathway activation produced glutamatergic and pro-oxidative metabolites (3-HK), suggesting that chronic stress accelerates glutamatergic excitotoxicity and oxidative stress. We show here that a chronic treatment with the IDO (indole dioxygenase) inhibitor 1-methyl-tryptophan (1MT) or antidepressant fluoxetine were able to reverse TRP/KYN abnormalities caused by chronic stress. These data suggest that TRP/KYN pathway would play a central role in the pathophysiology of stress-induced bio-behavioural abnormalities.

**Methods:** Mice were confronting the unpredictable chronic mild stress (UCMS) procedure and brain KP metabolites were analysed in relevant brain structures and in the periphery, in saline, 1-MT and fluoxetine treated animals.

**Results:** 1-MT and FLX reverse most of UCMS-induced behavioural abnormalities induced by UCMS and reverse various metabolic alterations of the KP (peripherally and centrally).

**Conclusions:** Our results show that inhibition of the KP by 1MT is as effective as fluoxetine as an antidepressant treatment in the UCMS mice. They show that inhibiting KP subsequently reduces the production of pro-oxidative /neurotoxic metabolic substrates in relevant structures. They suggest that KP would play a central role in the link between neuroinflammation and oxidative stress abnormalities in chronic stress induced mood disorders.
